Rothe, A., R. D. Jachimowicz, S. Borchmann, M. Madlener, J. Keßler, K. S. Reiners, M. Sauer, H. P. Hansen, R. T. Ullrich, S. Chatterjee, P. Borchmann, P. Yazaki, T. C. Koslowsky, A. Engert, L. C. Heukamp, M. Hallek and E. P. Von Strandmann: The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma. In: International Journal of Cancer 134, 12, 2829-2840 (2014).
doi: 10.1002/ijc.28609
Chatterjee, S., C. Wieczorek, J. Schöttle, M. Siobal, Y. Hinze, T. Franz, A. Florin, J. M. Adamczak, L. C. Heukamp, B. Neumaier and R. T. Ullrich: Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer. In: Cancer Research 74, 10, 2816-2824 (2014).
doi: 10.1158/0008-5472.CAN-13-2986
Chatterjee, S., C. Wieczorek, J. Schöttle, M. Siobal, Y. Hinze, T. Franz, A. Florin, J. M. Adamczak, L. C. Heukamp, B. Neumaier and R. T. Ullrich: Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer. In: Cancer Research 74, 10, 2816-2824 (2014).
doi: 10.1158/0008-5472.CAN-13-2986
Chatterjee, S., C. Wieczorek, J. Schöttle, M. Siobal, Y. Hinze, T. Franz, A. Florin, J. M. Adamczak, L. C. Heukamp, B. Neumaier and R. T. Ullrich: Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer. In: Cancer Research 74, 10, 2816-2824 (2014).
doi: 10.1158/0008-5472.CAN-13-2986
Chatterjee, S., C. Wieczorek, J. Schöttle, M. Siobal, Y. Hinze, T. Franz, A. Florin, J. M. Adamczak, L. C. Heukamp, B. Neumaier and R. T. Ullrich: Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer. In: Cancer Research 74, 10, 2816-2824 (2014).
doi: 10.1158/0008-5472.CAN-13-2986
Chatterjee, S., L. C. Heukamp, M. Siobal, J. Schöttle, C. Wieczorek, M. Peifer, D. Frasca, M. Koker, K. König, L. Meder, D. Rauh, R. Buettner, J. Wolf, R. A. Brekken, B. Neumaier, G. Christofori, R. K. Thomas and R. T. Ullrich: Tumor vegf:vegfr2 autocrine feed-forward loop triggers angiogenesis in lung cancer. In: Journal of Clinical Investigation 123, 4, 1732-1740 (2013).
doi: 10.1172/JCI65385
Heukamp, L. C., T. Thor, A. Schramm, K. De Preter, C. Kumps, B. de Wilde, A. Odersky, M. Peifer, S. Lindner, A. Spruessel, F. Pattyn, P. Mestdagh, B. Menten, S. Kuhfittig-Kulle, A. Kuenkele, K. Koenig, L. Meder, S. Chatterjee, R. T. Ullrich, S. Schulte, J. Vandesompele, F. Speleman, R. Buettner, A. Eggert and J. H. Schulte: Targeted expression of mutated ALK induces neuroblastoma in transgenic mice. In: Science Translational Medicine 4, 141, Seq. No.: 141ra91 (2012).
doi: 10.1126/scitranslmed.3003967
Heukamp, L. C., T. Thor, A. Schramm, K. De Preter, C. Kumps, B. de Wilde, A. Odersky, M. Peifer, S. Lindner, A. Spruessel, F. Pattyn, P. Mestdagh, B. Menten, S. Kuhfittig-Kulle, A. Kuenkele, K. Koenig, L. Meder, S. Chatterjee, R. T. Ullrich, S. Schulte, J. Vandesompele, F. Speleman, R. Buettner, A. Eggert and J. H. Schulte: Targeted expression of mutated ALK induces neuroblastoma in transgenic mice. In: Science Translational Medicine 4, 141, Seq. No.: 141ra91 (2012).
doi: 10.1126/scitranslmed.3003967
Bill, A., A. Schmitz, B. Albertoni, J.-N. Song, L. C. Heukamp, D. Walrafen, F. Thorwirth, P. J. Verveer, S. Zimmer, L. Meffert, A. Schreiber, S. Chatterjee, R. K. Thomas, R. T. Ullrich, T. Lang and M. Famulok: Cytohesins Are Cytoplasmic ErbB Receptor Activators. In: Cell 143, 2, 201-211, Seq. No.: 1 (2010).
url: http://dx.doi.org/10.1016/j.cell.2010.09.011
Bill, A., A. Schmitz, B. Albertoni, J.-N. Song, L. C. Heukamp, D. Walrafen, F. Thorwirth, P. J. Verveer, S. Zimmer, L. Meffert, A. Schreiber, S. Chatterjee, R. K. Thomas, R. T. Ullrich, T. Lang and M. Famulok: Cytohesins are cytoplasmic ErbB receptor activators. In: Cell 143, 2, 201-211 (2010).
doi: 10.1016/j.cell.2010.09.011
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.